Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Terminated 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Glioblastoma 12Prostatic Neoplasms 11Breast Neoplasms 10Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 5Oropharyngeal Neoplasms 5Neoplasms 4Histiocytoma, Malignant Fibrous 4Head and Neck Neoplasms 4Brain Neoplasms 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Synovial 3Rhabdomyosarcoma 3Melanoma 3Liposarcoma 3Leiomyosarcoma 3Hodgkin Disease 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2

Interventions

Rituximab 25Lenalidomide 20Cyclophosphamide 18obinutuzumab 8Vincristine 8Doxorubicin 8Prednisone 7Bendamustine Hydrochloride 7tazemetostat 6ibrutinib 6Biopsy 6venetoclax 5pembrolizumab 5fludarabine 5Specimen Handling 5CT-P10 5fludarabine phosphate 4R-CHOP protocol 4Peripheral Blood Stem Cell Transplantation 4Nivolumab 4Magnetic Resonance Spectroscopy 4Prednisolone 3Etoposide 3tocilizumab 2copanlisib 2axicabtagene ciloleucel 2atezolizumab 2acalabrutinib 2abexinostat 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lymphoma, Follicular × Radiation × Clear all
NCT03528642 2026-05-13

Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma

National Cancer Institute (NCI)

Phase 1 Active not recruiting
40 enrolled
CNSLymphoid

Astrocytoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡